CHARTER ON ACCESS TO HEALTH (A2H) IN DEVELOPING COUNTRIES: OUR
APPROACH
‘No access to healthcare’
But these people represent
Leverage our expertise & core competencies across the
health
value chain
Overcome barriers to sustainable access to
health solutions
Address unmet health needs of underserved populations
regardless
of geography or ability to pay
Challenge In Developing Countries
Our Commitment
93%of the world’s disease burden
18%of world income
€
$ £
11%of global health spending
complex, multi-faceted, challenge; no-one size
fits all
RANKED #4 ACCESS TO MEDICINES INDEX 2016
Countries Where We Help Expand Access To Health
Developed countries
IN THE ATM 2016 INDEX
In access to health, there are many challenges that require
innovative solutions. Through our sustainable access to health
initiatives, we are making a difference.Dr Stefan Oschmann, Vice
Chairman, Executive Board, Merck KGaA, Darmstadt, Germany
Our aim is to make access to health (A2H) a part of our DNA. In
order to achieve the change we seek, we understand collaboration
and partnership are key to tackling complex access challenges.Dr
Frédérique Santerre, Global Head, Access to Health (A2H), Merck
KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt
Germany was founded in
1668 and is a leading science and technology
company.
1.3 BILLION
4TH 106 Developing Countries Where We Help Improve Access to
Health
Merck KGaA Darmstadt, Germany
For more information on our Charter on Access to Health in
Developing Countries, please contact: [email protected] or refer to
our A2H website:
http://www.emdgroup.com/emd/responsibility/access_to_health/access_to_health.html
November 2016
Of the approximately 451 medicines & vaccines on the 2015
WHO Essential Medicines List (EML), we provide 44
medicines in addition to 21 for high-burden diseases in
developing countries, including
Africa, Asia and Latin America.
Products available in +- 2/3rds Least Developed Countries
1. Business for Social Responsibility (BSR) Guiding Principles
on Access to Healthcare (GPAH) Merck KGaA, Darmstadt, Germany
initiatives highlighted as best practices
2. Access to Medicine Index 2016 highlighted best practices
Merck KGaA, Darmstadt Germany 4AS OF ACCESS
OUR ACCESS APPROACH
AVAILABILITYResearch & develop
health solutions
ACCESSIBILITYStrengthen supply
chains and develop localized solutions
AFFORDABILITYAssist those unable to pay for health solutions
AWARENESSEmpower with tools, knowledge, information &
skills
Our Commitment
Putting Our Commitment Into Action: Some Examples
Partnering for ChangeWe cannot do it alone. We engage and
participate with dialogue and partnerships across the global health
spectrum, and works with all stakeholders to deliver sustainable
global health outcomes.
1. AVAILABILITY • Pediatric Praziquantel
Consortium: International non-profit public-private partnership
to develop a pediatric formulation for young children with
Schistosomiasis1
• Medicines for Malaria Venture (MMV): Partnership to develop a
new anti-malarial compound to help fight malarial drug
resistance
• Muse Auto CD4/CD4% system: A diagnostic kit for monitoring T
cells in adults and children. Currently exploring the development
of an HIV/Malaria diagnostic kit.
2. ACCESSIBILITY• Rural Pharmacy:
Pre-equipped shipping container “pharmacy” transported to rural
communities in Africa
• River Ambulance: Helps expand access to health services and
solutions to underserved local populations along the Narmada River
in partnership with the NGO Narmada Samagra1
• Virtual Plant Team: Provide support, expertise & regular
training to local party plant managers.2
3. AWARENESS• Su-Swastha project:
Community-level engagement & educative health programs on
primary healthcare, women & children’s health & prevention
in rural areas in India2
• Capacity Advancement Program: Collaboration in Africa to raise
diabetes awareness
• Access dialogues: Platform for information exchange and best
practice sharing among public and private sector stakeholders.1
4. AFFORDABILITY • WIPO Re:Search:
Open innovation platform for knowledge and IP sharing platform
to accelerate early discovery for infectious diseases.
• Merck KGaA, Darmstadt, Germany Praziquantel Donation Program:
Since 2007, Merck KGaA, Darmstadt, Germany has been partnering with
WHO in the fight against schistosomiasis. By the end of 2014, more
than 54 million patients, primarily including children have been
treated with praziquantel.
A A
A A
ESSENTIAL MEDICINES TO 74 DEVELOPING COUNTRIES:
Latin America
Asia
Africa
12 18
35
